Ruhi Khan

Ruhi serves as Chief Business Officer for Caribou Biosciences, responsible for developing and executing on business development strategy. She brings over 20 years of business development and investment management experience focused on the biotechnology and pharmaceutical industries. Most recently, Ruhi was the founder of an advisory firm that provided business development and finance advice to life sciences companies. In this role she had extensive senior management experience as head of business development for several oncology-focused companies. Previously, Ruhi was the Head and Vice President of Business Development for Acorda Therapeutics, Inc. Prior to Acorda, she worked in a similar capacity at Lexicon Pharmaceuticals, Inc. She started her career in venture capital with Fidelity Biosciences Group (now F-Prime Capital) and MPM Capital Advisors. Ruhi holds an M.B.A. in health care management from The Wharton School, University of Pennsylvania, and an A.B. in biology from Harvard College.